The
development of drug delivery systems using nanoparticles as
carriers for small and large therapeutic molecules remains a rapidly
growing area of research. The advantages of using proteins to prepare
nanoparticles for drug delivery applications include their abundance
in natural sources, biocompatibility, biodegradability, easy synthesis
process, and cost-effectiveness. In contrast to several particulate
systems like nanoparticles from metallic and inorganic/synthetic sources,
the protein nanoparticles do not have limitations such as potential
toxicity, large size, accumulation, or rapid clearance from the body.
In addition, protein-based nanoparticles offer the opportunity for
surface modification by conjugation of other protein and carbohydrate
ligands. This enables targeted delivery to the desired tissue and
organ, which further reduces systemic toxicity. The use of protein
nanoparticles for such applications could therefore prove to be a
better alternative to maneuver and improve the pharmacokinetic and
pharmacodynamic properties of the various types of drug molecules.
In this review, while focusing on the properties of a few proteins
such as the silk protein fibroin, we attempt to provide an overview
of the existing protein-based nanoparticles. We discuss various methods
for the synthesis of this class of nanoparticles. The review brings
forth some of the factors that are important for the design of this
class of nanoparticles and highlights the applications of the nanoparticles
obtained from these proteins.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.